Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas – a single centre experience

Long-term outcomes of high dose treatment and autologous stem cell transplantation in follicular and mantle cell lymphomas – a single centre experience

Advanced follicular lymphoma (FL) and mantle cell lymphoma (MCL) are incurable diseases with conventional treatment. The high dose treatment (HDT) with autologous stem cell transplantation (ASCT), however, offers a certain proportion of these patients the prospect of a prolonged disease-free and ove...

Full description

Bibliographic Details
Main Authors: Boltezar Lucka, Pintaric Karlo, Pretnar Jože, Pohar Perme Maja, Novakovic Barbara Jezersek
Format: Article
Language:English
Published: Sciendo 2016-06-01
Series:Radiology and Oncology
Subjects:
follicular lymphoma
mantle cell lymphoma
autologous stem cell transplantation
overall survival
hematological malignancies
Online Access:https://doi.org/10.1515/raon-2016-0040
Description
Summary:Advanced follicular lymphoma (FL) and mantle cell lymphoma (MCL) are incurable diseases with conventional treatment. The high dose treatment (HDT) with autologous stem cell transplantation (ASCT), however, offers a certain proportion of these patients the prospect of a prolonged disease-free and overall survival. The aim of this study was to investigate the event free survival (EFS) and overall survival (OS) in patients with FL and MCL treated with ASCT.
ISSN:1581-3207

Similar Items